Abstract:Objective: Cardiovascular disease (CVD) is a global health crisis and a leading cause of mortality. The intricate interplay between vascular contractility and mitochondrial function is central to CVD pathogenesis. The progranulin gene (GRN) encodes glycoprotein progranulin (PGRN), a ubiquitous molecule with known anti-inflammatory property. However, the role of PGRN in CVD remains enigmatic. In this study, we sought to dissect the significance of PGRN in the regulation vascular contractility and investigate the interface between PGRN and mitochondrial quality. Method: Our investigation utilized aortae from male and female C57BL6/J wild-type (PGRN+/+) and B6(Cg)-Grntm1.1Aidi/J (PGRN-/-) mice, encompassing wire myograph assays to assess vascular contractility and primary aortic vascular smooth muscle cells (VSMCs) for mechanistic insights. Results: Our results showed suppression of contractile activity in PGRN-/- VSMCs and aorta, followed by reduced α-smooth muscle actin expression. Mechanistically, PGRN deficiency impaired mitochondrial oxygen consumption rate (OCR), complex I activity, mitochondrial turnover, and mitochondrial redox signaling, while restoration of PGRN levels in aortae from PGRN-/- mice via lentivirus delivery ameliorated contractility and boosted OCR. In addition, VSMC overexpressing PGRN displayed higher mitochondrial respiration and complex I activity accompanied by cellular hypercontractility. Furthermore, increased PGRN triggered lysosome biogenesis by regulating transcription factor EB and accelerated mitophagy flux in VSMC, while treatment with spermidine, an autophagy inducer, improved mitochondrial phenotype and enhanced vascular contractility. Finally, angiotensin II failed to induce vascular contractility in PGRN-/- suggesting a key role of PGRN to maintain the vascular tone. Conclusion: Our findings suggest that PGRN preserves the vascular contractility via regulating mitophagy flux, mitochondrial complex I activity, and redox signaling. Therefore, loss of PGRN function appears as a pivotal risk factor in CVD development.

PGRN Acts As a Novel Regulator of Mitochondrial Homeostasis by Facilitating Mitophagy and Mitochondrial Biogenesis to Prevent Podocyte Injury in Diabetic Nephropathy

Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions

Emerging Protective Actions of PGC-1α in Diabetic Nephropathy

Protective Role of PGC-1α in Diabetic Nephropathy is Associated with the Inhibition of ROS Through Mitochondrial Dynamic Remodeling.

Progranulin Protects Against Renal Ischemia/reperfusion Injury in Mice.

PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms

Pgrn Induces Impaired Insulin Sensitivity And Defective Autophagy In Hepatic Insulin Resistance

Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

Progranulin protects against renal ischemia|[sol]|reperfusion injury in mice

Administration of Progranulin (PGRN) Triggers ER Stress and Impairs Insulin Sensitivity Via PERK-eIF2α-dependent Manner

Genipin Inhibits Mitochondrial Uncoupling Protein 2 Expression And Ameliorates Podocyte Injury In Diabetic Mice

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

PPARγ and PGC-1α activators protect against diabetic nephropathy by suppressing the inflammation and NF-κB activation

Promoting mitochondrial dynamics by inhibiting the PINK1/PRKN pathway to relieve diabetic nephropathy

PPAR gamma and PGC-1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF-kappaB activation

Progranulin Induces Adipose Insulin Resistance and Autophagic Imbalance Via TNFR1 in Mice.

Grape seed proanthocyanidin extracts ameliorate podocyte injury by activating peroxisome proliferator-activated receptor-γ coactivator 1α in low-dose streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats.

Mitophagy: A Novel Therapeutic Target for Treating DN

Adjusted vascular contractility relies on integrity of progranulin pathway: Insights into mitochondrial function

PGRN Exerts Inflammatory Effects Via SIRT1-NF-κB in Adipose Insulin Resistance.